Company Overview

We are a clinical stage biopharmaceutical company focused on drug development and delivery in diabetes and other cardiometabolic diseases.

We are applying our proprietary technology platform, Arestat®, to develop a portfolio of proprietary products that address areas of high unmet need in high value markets, as well as working with leading pharmaceutical and biotechnology companies to deliver enhanced therapeutics.

 

Media & Events

Investor presentation – March 2026

16 March 2026

Arecor Presentation at Oppenheimer Annual Healthcare MedTech & Services Conference on Monday 16 March 2026 at 9:20am ET. Register to listen to the webcast

9 March 2026

Arecor talks to Biotech TV

23 February 2026

Contact: ir@arecor.com